Key result
Point-of-care testing for cardiac troponin T significantly reduced median overall hospital stay (149.9 h vs 209.3 h) in patients eligible for early discharge compared to central laboratory testing.
Why the study?
Does point-of-care testing for cardiac troponin T reduce length of stay or mortality in patients with chest pain and suspected acute coronary syndrome?
RCT (n=263)
randomized
No
Does point-of-care testing for cardiac troponin T reduce length of stay or mortality in patients with chest pain and suspected acute coronary syndrome?
Point-of-care troponin testing combined with structured decision-making can significantly reduce hospital length of stay for early-discharge eligible patients with suspected acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Supports point-of-care troponin T testing to shorten stays in eligible suspected ACS patients; extends RCT evidence beyond central laboratory standards.
Collinson et al. (2004) conducted an RCT in chest pain and suspected acute coronary syndrome (n=263). Point-of-care testing (POCT) for cardiac troponin T vs. Central laboratory testing (CLT) was evaluated on Diagnostic accuracy, result turnaround time, mortality, and length of stay. Point-of-care testing for cardiac troponin T significantly reduced median overall hospital stay (149.9 h vs 209.3 h) in patients eligible for early discharge compared to central laboratory testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: